Evidence map›Paper›PMID 36183490›Full record

ArticleEnvironment international2022

Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.

Anna K Porter, Sarah E Kleinschmidt, Kara L Andres, Courtney N Reusch, Ryan M Krisko, Oyebode A Taiwo, Geary W Olsen, Matthew P Longnecker

Open access · goldAbstract read
In one paragraph

Article in Environment international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Occurrence of COVID-19 and serumGlobal epidemiology · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anna K PorterRamboll U.S. Consulting, 3214 Charles B. Root Wynd, Suite 130, Raleigh, NC 27612, United States. Electronic address: aporter@ramboll.com.
Sarah E Kleinschmidt3M Company, Corporate Occupational Medicine, St. Paul, MN 55144, United States.
Kara L Andres3M Company, Corporate Occupational Medicine, St. Paul, MN 55144, United States.
Courtney N Reusch3M Company, Corporate Occupational Medicine, St. Paul, MN 55144, United States.
Ryan M Krisko3M Company, Environment, Health, Safety and Product Stewardship, St. Paul, MN 55144, United States.
Oyebode A Taiwo3M Company, Corporate Occupational Medicine, St. Paul, MN 55144, United States.
Geary W Olsen3M Company, Corporate Occupational Medicine, St. Paul, MN 55144, United States.
Matthew P LongneckerRamboll U.S. Consulting, 3214 Charles B. Root Wynd, Suite 130, Raleigh, NC 27612, United States.
3M (United States) · USLand Stewardship Project · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a broad class of synthetic chemicals; some are present in most humans in developed countries. Several studies have shown associations between certain PFAS, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), and reduced antibody concentration after vaccination against diseases such as Tetanus. Recent studies have reported associations between COVID-19 occurrence and exposure to certain types of PFAS. However, studies of antibody concentration after COVID-19 vaccination in relation to PFAS serum concentrations have not been reported. We examined COVID-19 antibody responses to vaccines and PFAS serum concentrations among employees and retirees from two 3M facilities, one of which historically manufactured PFOS, PFOA, and perfluorohexane sulfonic acid (PFHxS). Participants completed enrollment and follow-up study visits in the Spring of 2021, when vaccines were widely available. In total 415 participants with 757 observations were included in repeated measures analyses. Log-transformed concentrations of anti-spike IgG and neutralizing antibodies were modeled in relation to concentration of PFAS at enrollment after adjusting for antigenic stimulus group (9 groups determined by COVID-19 history and number and type of vaccination) and other variables. The fully adjusted IgG concentration was 3.45 percent lower (95% CI -7.03, 0.26) per 14.5 ng/mL (interquartile range) increase in PFOS; results for neutralizing antibody and PFOS were similar. For PFOA, PFHxS, and perfluorononanoic acid (PFNA), the results were comparable to those for PFOS, though of smaller magnitude. In our study data, the fully adjusted coefficients relating concentration of vaccine-induced antibodies to COVID-19 and interquartile range difference in serum concentration of PFOS, PFOA, PFHxS, and PFNA were inverse but small with confidence intervals that included zero. Our analysis showed that the coefficient for the four PFAS examined in detail was considerably affected by adjustment for antigenic stimulus group.

Indexed as

Alkanesulfonic AcidsCOVID-19Environmental PollutantsFluorocarbonsAntibodies, NeutralizingAntibody FormationCaprylatesCOVID-19 VaccinesFollow-Up StudiesHumansImmunoglobulin GSulfonic AcidsAlkanesulfonic AcidsAntibodies, NeutralizingCaprylatesCOVID-19 VaccinesEnvironmental PollutantsFluorocarbonsImmunoglobulin Gperflexaneperfluorooctane sulfonic acidperfluorooctanoic acidSulfonic AcidsCoronavirus disease 2019COVID-19Perfluoroalkyl substancesPFASPolyfluoroalkyl substancesVaccine

Identifiers

PMID36183490
PMCPMC9489981
OpenAlexW4296620604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.